Delivery Order SPE2DB20D2014-SPE2DB25FA79G

Award Date 1/14/25
Potential Completion Date 1/15/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,408.41 firm-fixed-price delivery order is for the supply of Injectafer 750 mg/15 ml vials, with a period of performance through March 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,518.76 firm fixed-price delivery order is for Injectafer 750 mg/15 ml vials, with a period of performance through November 13, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Injectafer 750 mg/15 ml vials. The $10,756 firm fixed-price contract has a completion date of February 20, 2025 and is not set aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $10,228.80 firm fixed price contract is for the provision of Injectafer 750 mg/15 ml vials, with a period of performance through November 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a broad range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Injectafer 750 mg/15 ml vials. The contract is a Delivery Order valued at $14,302.44, with a period of performance ending on April 27, 2023. It is a Firm Fixed Price contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
The federal contract award is for the delivery of Injectafer 750 mg/15 ml vials, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The $17,159.20 firm fixed price delivery order has a completion date of June 12, 2025 and was awarded on June 11, 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a substantial...
This federal contract award is a delivery order with a ceiling value of $19,228.50 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of INJECTAFER 750 MG/15 ML VIAL 15ML, a medical product, with a period of performance through March 11, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,398.11 firm fixed-price delivery order is for the supply of Injectafer 750 mg/15 ml vials, a specialty medication. The contract has an ultimate completion date of October 31, 2024 and was awarded on October 30, 2024. The contract is not designated as a set-aside. It is part of a larger $999,999,999 Indefinite...
This federal contract award is for the delivery of Injectafer 750 mg/15 ml vials to the Defense Logistics Agency (DLA). The contract, valued at $8,202.55, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price and is a delivery order with a completion date of November 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,469.23, is a delivery order for the injectable medication Injectafer 750 mg/15 ml vial. The contract has a completion date of February 26, 2025 and uses a firm fixed price pricing type. This contract award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FA79G
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,907.20 firm fixed-price delivery order is for the supply of Injectafer, a 750 mg/15 ml vial medication, with a period of performance through January 15, 2025.

AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, AmerisourceBergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 4/16/25, 5:47 PM